#	Pagina
attuale pagina	/open-h2020/projects/207132/index.html

Opendata, web and dolomites

Accordion Bioreactor

An innovative high capacity Accordion bioreactor technology for high performance and low cost microalgae production

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Accordion Bioreactor project word cloud

Explore the words cloud of the Accordion Bioreactor project. It provides you a very rough idea of what is the project "Accordion Bioreactor" about.

intent wave ife investment expanding contributes microalgae configuration good food weak supply quality vital closed efficiency supplied university describes arizona initial ingredients loi supplements raised ua industrial entities technologies cheaper efficient norwegian multiple biopharmia contamination expertise norway competitors proprietary access patented close modular accordion bioreactors productivity risk 2012 intends experts industries private algae feed market biomass extensive venture letters platform strains segments decreased solutions company aquaculture minimises cultivation capital position easily proven lower foreign customers bioreactor million demonstrated strengthen raw competing frame clients collaborations energy innovation comprising

Project "Accordion Bioreactor" data sheet

The following table provides information about the project.

Coordinator	BIOPHARMIA AS Organization address address: PO Box 34 Kjelsås city: OSLO postcode: 411 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Norway [NO]
Project website	http://www.biopharmia.no
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.2.5. (Cross-cutting marine and maritime research) 2. H2020-EU.3.2.3. (Unlocking the potential of aquatic living resources) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2017
Duration (year-month-day)	from 2017-01-01 to 2017-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BIOPHARMIA AS BIOPHARMIA AS Organization address address: PO Box 34 Kjelsås city: OSLO postcode: 411 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	coordinator	50˙000.00

Map

Project objective

Access to vital raw ingredients for food/feed production is an increasing challenge in several industries. Biopharmia is a Norwegian company focusing on cultivation of microalgae through its development of a proprietary bioreactor. Through years of expertise and collaborations with experts in the field of microalgae growth, Biopharmia have developed and patented the Accordion bioreactor, a proven and efficient platform for industrial scale production of high quality microalgae, at lower energy and decreased production cost, compared to other solutions. This technology aims to strengthen Europe’s position in the microalgae market, which is currently weak due to cheaper, low quality foreign competitors. The technology describes the unique wave configuration comprising the frame work of the bioreactor, which contributes to higher productivity and lower cost of production and investment when compared to competing technologies. The modular design of this closed system greatly minimises the risk of contamination and can be easily adapted to large scale production. Biopharmia need to undertake the proposed innovation project to develop and further test the Accordion technology with multiple algae strains. The company has a close collaboration with the University of Arizona (UA) and has demonstrated the efficiency and productivity of its bioreactors through extensive testing at UA. Biopharmia has supplied biomass to a number of entities in Norway with very good results. Biopharmia has Letters of Intent about supply of biomass to two Norwegian customers in different segments, food supplements and aquaculture. In 2012 the company raised €1 million in private venture capital from IFE Venture. Biopharmia intends to establish initial production using the Accordion technology for the clients the company have an LOI with before expanding production.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACCORDION BIOREACTOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACCORDION BIOREACTOR" are provided by the European Opendata Portal: CORDIS opendata.